User profiles for "author:W Liu"

William J. Liu

- Verified email at ivdc.chinacdc.cn - Cited by 27645

WEI-TING LIU

- Verified email at stanford.edu - Cited by 6603

[HTML][HTML] The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms

R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle… - Leukemia, 2022 - nature.com
We herein present an overview of the upcoming 5th edition of the World Health Organization
Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid …

Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking

M Wang, JJ Carver, VV Phelan, LM Sanchez… - Nature …, 2016 - nature.com
The potential of the diverse chemistries present in natural products (NP) for biotechnology
and medicine remains untapped because NP databases are not searchable with raw data …

Epidemiology, genetic recombination, and pathogenesis of coronaviruses

S Su, G Wong, W Shi, J Liu, ACK Lai, J Zhou, W Liu… - Trends in …, 2016 - cell.com
Human coronaviruses (HCoVs) were first described in the 1960s for patients with the
common cold. Since then, more HCoVs have been discovered, including those that cause …

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

R Lu, X Zhao, J Li, P Niu, B Yang, H Wu, W Wang… - The lancet, 2020 - thelancet.com
Summary Background In late December, 2019, patients presenting with viral pneumonia
due to an unidentified microbial agent were reported in Wuhan, China. A novel coronavirus …

[PDF][PDF] The immune landscape of cancer

…, Z Ju, RS Kanchi, A Korkut, J Li, H Liang, S Ling, W Liu… - Immunity, 2018 - cell.com
We performed an extensive immunogenomic analysis of more than 10,000 tumors
comprising 33 diverse cancer types by utilizing data compiled by TCGA. Across cancer …

[HTML][HTML] A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19

B Cao, Y Wang, D Wen, W Liu, J Wang… - New England journal …, 2020 - Mass Medical Soc
Background No therapeutics have yet been proven effective for the treatment of severe
illness caused by SARS-CoV-2. Methods We conducted a randomized, controlled, open …

Design and construction of the BESIII detector

M Ablikim, ZH An, JZ Bai, N Berger, JM Bian… - Nuclear Instruments and …, 2010 - Elsevier
This paper will discuss the design and construction of BESIII, which is designed to study
physics in the τ-charm energy region utilizing the new high luminosity BEPCII double ring e+ …

[PDF][PDF] Oncogenic signaling pathways in the cancer genome atlas

…, Z Ju, RS Kanchi, A Korkut, J Li, S Ling, W Liu… - Cell, 2018 - cell.com
Genetic alterations in signaling pathways that control cell-cycle progression, apoptosis, and
cell growth are common hallmarks of cancer, but the extent, mechanisms, and co …

An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19

…, EP Kadar, AS Kalgutkar, JC Lee, J Lee, W Liu… - Science, 2021 - science.org
The worldwide outbreak of COVID-19 caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has become a global pandemic. Alongside vaccines, antiviral …

[PDF][PDF] The molecular taxonomy of primary prostate cancer

…, P Lin, WM Linehan, S Ling, SM Lippman, J Liu, W Liu… - Cell, 2015 - cell.com
There is substantial heterogeneity among primary prostate cancers, evident in the spectrum
of molecular abnormalities and its variable clinical course. As part of The Cancer Genome …